Therefore, reviewing the regimen and dosage of immunosuppressive medications before and after PD-1 inhibitor treatment in these four renal transplant patients and exploring why these patients with advanced melanoma were able to maintain graft function after PD-1 inhibitor treatment are necessary. This evidence concerns the gene PDCD1 and melanoma.